PSORIASIS Is ustekinumab superior to etanercept for psoriasis?

被引:6
|
作者
Kuhn, Annegret [1 ]
Luger, Thomas A. [1 ]
机构
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
关键词
INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; TNF INHIBITION; TRIAL; EFFICACY; SAFETY;
D O I
10.1038/nrrheum.2010.134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Both etanercept and ustekinumab have been shown to be strikingly effective in patients with psoriasis. A phase III trial comparing these two biologic agents for the treatment of moderate-to-severe psoriasis found that ustekinumab was superior to high-dose etanercept over a 12-week period; however, several questions remain to be addressed.
引用
收藏
页码:500 / 501
页数:3
相关论文
共 50 条
  • [31] Etanercept in juvenile psoriasis
    Beikert, F. C.
    Augustin, M.
    Radtke, M. A.
    HAUTARZT, 2012, 63 (05): : 406 - 410
  • [32] Etanercept: treatment of psoriasis
    Girault, V
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2005, 132 (11): : 933 - 933
  • [33] Etanercept monotherapy in psoriasis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2004, 6 (4) : 290 - 291
  • [34] Characterizing patients with psoriasis on injectable biologics adalimumab, etanercept, and ustekinumab: A chart review study
    Zhang, Mingliang
    Goren, Amir
    Lee, Seina
    DiBonaventura, Marco D.
    Olson, William H.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (04) : 339 - 345
  • [35] Dosing patterns with and cost impact of etanercept and ustekinumab for psoriasis in a real-world setting
    Bonafede, Machaon
    Tang, Derek
    Wilson, Kathleen
    Huang, Alice
    Harrison, David
    Stolshek, Bradley
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB243 - AB243
  • [36] Comparison of efficacy of ixekizumab and ustekinumab in the treatment of plaque psoriasis: An indirect comparison via etanercept
    Schacht, Alexander
    Petto, Helmut
    Brnabic, Alan
    Kadziola, Zbigniew
    Mallbris, Lotus
    Wilhelm, Stefan
    Dutronc, Yves
    Hartz, Susan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB241 - AB241
  • [37] Adherence to Ustekinumab in Psoriasis Patients
    Sandoval, Laura F.
    Huang, Karen E.
    Feldman, Steven R.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (10) : 1090 - 1092
  • [38] Efficacy of Ustekinumab in Palmoplantar Psoriasis
    Livideanu, C. Bulai
    Lahfa, M.
    Mazereeuw-Hautier, J.
    Paul, C.
    DERMATOLOGY, 2010, 221 (04) : 321 - 323
  • [39] Ustekinumab for chronic plaque psoriasis
    Bartlett, Brenda L.
    Tyring, Stephen K.
    LANCET, 2008, 371 (9625): : 1639 - 1640
  • [40] Brodalumab versus ustekinumab in psoriasis
    Fioranelli, Massimo
    Roccia, Maria Grazia
    Lotti, Torello
    DERMATOLOGIC THERAPY, 2016, 29 (05) : 298 - 298